pulseData's recent patent award provides essential component to solve chronic illness Healthcare data science company opens new frontier for AI applications in chronic care delivery News provided by Share this article Share this article NEW YORK, May 18, 2021 /PRNewswire/ -- While machine learning has been used in healthcare applications for years, we are now entering a new era where previously undetectable disease can be identified, progression can be predicted and interventions can be planned proactively to stop or slow disease progression. Today, pulseData— a software company that builds adaptive, predictive engines to identify patients at risk of avoidable medical outcomes — announces that it was awarded a U.S. patent for a machine learning technology which detects the risk of renal decline, validating that there are repeatable, provable methods for predicting acute events. The implications of this technology are dramatic for the 37 million Americans that suffer from Chronic Kidney Disease (CKD). This technology helps to prevent and avoid costly and severe events before they happen, rather than waiting for a person to end up in the emergency room.